Delivery Order 36F79722D0090-36C26024F0074
Award Date
2/8/24
Potential Completion Date
2/7/25
Potential Value
$109K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Grifols USA LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Los Angeles, CA 90032, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) awarded a $100,800.00 Firm Fixed Price Delivery Order contract to Grifols USA LLC for the provision of PROLASTIN-C, an alpha1-proteinase inhibitor drug used to treat alpha1-antitrypsin deficiency. This contract is part of Grifols' $1.38 billion Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the VA. The contract has a period of performance through February 8, 2026 and was awarded without a set-aside designation,...
This delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awards Grifols USA LLC $502,920.80 to supply Prolastin-C Liquid, Human 1000mg/vial under the firm fixed price contract. The order is placed against Grifols' Pharmaceuticals and Drugs Schedule contract with the General Services Administration and requires delivery by September 30, 2023. No set-aside provision was applied to this order. Grifols will provide the...
Grifols USA LLC was awarded an $11,580.80 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The delivery order, which has no set-aside designation and a completion date of June 13, 2023, is for the purchase of PROLASTIN-C. Performance will take place in Los Angeles, California. The contract utilizes firm fixed pricing and draws from GSA Schedule 61-IB to...
The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, for the provision of the drug PROLASTIN. The $202,942.32 firm fixed price contract is a delivery order issued under Grifols' Pharmaceuticals and Drugs GSA Schedule contract. The contract does not utilize any small business set-asides and has a performance period ending on April 15,...
This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Grifols USA LLC, a global healthcare company that specializes in plasma-derived medicines and pharmaceutical supplies. The contract, which is not a set-aside, is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, with a ceiling value of $288,931.30 and a completion date of September 30, 2024. Grifols USA LLC holds a Federal...
This federal contract award is to Grifols USA LLC, a global healthcare company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of PROLASTIN, a pharmaceutical product, with a potential value of $59,192.70. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is priced on a firm fixed price basis. The contract does not have a set-aside designation. Grifols USA LLC is the prime contractor...
This is a $319,369.68 delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The contract, which is not set aside, is for the delivery of the pharmaceutical product PROLASTIN C. It is a firm fixed price contract with a period of performance ending on September 30, 2020. Grifols Therapeutics LLC is a long-standing federal contractor, having...
This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of PROLASTIN-C, a pharmaceutical product, with a ceiling value of $214,014.72 and a period of performance through September 30, 2016. The contract is issued under the Pharmaceuticals and Drugs GSA Schedule vehicle and does not utilize...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $223,184.16, is for the provision of PROLASTIN C, a pharmaceutical product, to the VA under the Pharmaceuticals and Drugs GSA Schedule contract. The contract is a firm fixed-price delivery order with a period of performance ending on September 30, 2017. The contract was...
This federal contract award is for the delivery of PROLASTIN, a pharmaceutical product, to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The contract was awarded to the prime contractor Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract has a firm fixed price of $202,230.57 and a completion date of January 31, 2019. It was awarded on February 22, 2018 and is a BPA...